December 19, 2024
CLASP1 Recombinant Rabbit Monoclonal Antibody [JE43-19]
Product Name : CLASP1 Recombinant Rabbit Monoclonal Antibody [JE43-19]Predicted band size : 169 kDaObserved band size : 150 kDaSynonyms: 1700030C23Rik antibody 5730583A19Rik antibody B130045P17Rik antibody CLAP1_HUMAN antibody clasp1 antibody CLIP associating protein 1 antibody CLIP associating protein CLASP1 antibody CLIP-associating protein 1 antibody Cytoplasmic linker associated protein 1 antibody Cytoplasmic linker-associated protein 1 antibody 展开Function […]
CL12A Rabbit Polyclonal Antibody
Product Name : CL12A Rabbit Polyclonal AntibodyPredicted band size : Observed band size : Synonyms: C-type lectin domain family 12 member A antibody C-type lectin-like molecule 1 antibody CL12A_HUMAN antibody CLEC12A antibody CLL-1 antibody DCAL-2 antibody Dendritic cell-associated lectin 2 antibody MICL antibody Myeloid inhibitory C-type lectin-like receptor antibodyFunction : This gene encodes a member […]
CKR-6 Rabbit Polyclonal Antibody
Product Name : CKR-6 Rabbit Polyclonal AntibodyPredicted band size : Observed band size : Synonyms: BN 1 antibody BN1 antibody C C chemokine receptor type 6 antibody C C CKR 6 antibody C-C chemokine receptor type 6 antibody C-C CKR-6 antibody CC chemokine receptor type 6 antibody CC CKR 6 antibody CC R6 antibody CC-CKR-6 […]
VU 0364770
Product Name : VU 0364770Description:VU0364770 is a Positive allosteric modulator at mGlu4 receptors (EC50 = 290 nM in mGlu4-expressing HEK 293 cells). VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson’s disease.CAS: 61350-00-3Molecular Weight:232.67Formula: C12H9ClN2OChemical Name: N-(3-Chlorophenyl)-2-pyridinecarboxamideSmiles : O=C(NC1=CC(Cl)=CC=C1)C1=CC=CC=N1InChiKey: SUYUTNCKIOLMAJ-UHFFFAOYSA-NInChi : InChI=1S/C12H9ClN2O/c13-9-4-3-5-10(8-9)15-12(16)11-6-1-2-7-14-11/h1-8H,(H,15,16)Purity: ≥98% (or […]
CC-930
Product Name : CC-930Description:CC-930, also known as Tanzisertib, is a potent, selective, and orally active JNK inhibitor with potential antifibrotic activity. CC-930 entered Phase I clinical trials. Tanzisertib may have potential use for prevention and treatment of dermal fibrosis. Selective inhibition of JNK by CC-930 exerted potent antifibrotic effects in vitro and in different models […]